Selenium Antiviral Biotech
  • Home
  • About
  • Our Science
  • News
Select Page
TTUHSC researchers developing anti-viral drug for COVID-19

TTUHSC researchers developing anti-viral drug for COVID-19

by seantiviral | Jul 9, 2020 | COVID-19

Written by: Mark Hendricks Patented Peptide Creates Superoxide to Inactivate Virus One of the enduring images of the COVID-19 pandemic will be that of the SARS-CoV-2 virus with its numerous and distinctive prong-like appendages. Each of these members of the...

Recent Posts

  • TTUHSC researchers developing anti-viral drug for COVID-19

Selenium Antiviral Biotech.

The Selenium Antiviral Biotech is taking an integrated approach to developing drug candidates, through biomimicry, novel peptide screens through phage display, and binding optimization using machine learning.

main

Menu

Home
About
Our Science
News

Contact

Get In Touch

contact@seantiviral.tech

Copyright ©2025 SE Antiviral Biotech